breast cancer

An arrow incrementally going up stairs before pointing straight up Blue background
Biotech

BioNTech's ADC beats Roche’s Kadcyla in breast cancer phase 3

The study positions BioNTech’s partner Duality Biologics to seek approval for the HER2 candidate in China.
Nick Paul Taylor Sep 5, 2025 7:30am
An arrow incrementally going up stairs before pointing straight up Blue background

Celcuity's breast cancer combo hits goals, teeing up FDA filing

Jul 28, 2025 6:00am
oncology cancer test mammogram mammography breast cancer

FDA clears Clairity's 5-year breast cancer risk prediction tool

Jun 5, 2025 1:00pm
blood test vials

Guardant360-guided breast cancer therapy swaps boost survival

Jun 3, 2025 10:00am
On target clinical trial success bullseye score

AstraZeneca's breast cancer pill boosts PFS by 56% in phase 3

Jun 2, 2025 7:10am
layoffs

Arvinas lays off 33% of staff, axes Pfizer-partnered trials

May 1, 2025 8:50am